HMPL-002

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameHMPL-002
Drug Alias NameHMPL-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungHead and Neck Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHutchison Medipharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHutchison Medipharma Ltd
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell LungHead and Neck Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A